Jubilant Pharmova News

Jubilant Pharmova unit gets tax order

Jubilant Generics received an Income Tax order for FY23 with adjustments of ₹107.89 crore. The subsidiary plans to appeal the order.

Jubilant Pharmova Eyes Margin Gains from H2 FY27

Jubilant Pharmova's Chairman expects EBITDA margins to improve from H2 FY27 as Montreal production stabilises, while CFO Arun Kumar Sharma resigns effective May 22, 2026.

Jubilant Pharmova re-appoints MDs for 3 years

Jubilant Pharmova board approves re-appointment of Priyavrat Bhartia and Arjun Shanker Bhartia for three years from June 1, 2026, subject to shareholder approval.

Jubilant Pharmova appoints new CFO

Jubilant Pharmova appoints Ashish Mukkirwar as CFO effective May 23, 2026. Arun Kumar Sharma resigns to assume an advisory role.

Jubilant Pharmova Schedules Analyst Meet on May 25

Jubilant Pharmova has scheduled an in-person group meeting with Dalton Investments and Marval Capital on May 25, 2026, to discuss Q4 FY26 earnings.